(Q34775202)

4 August 2017

1 reference

title

Prognostic significance of HIV-associated oral lesions and their relation to therapy (English)

1 reference

4 August 2017

Warren Birnbaum

1

1 reference

4 August 2017

T A Hodgson

2

1 reference

4 August 2017

P A Reichart

3

1 reference

4 August 2017

W Sherson

4

1 reference

4 August 2017

W Nittayananta

5

1 reference

4 August 2017

T E Axell

6

1 reference

4 August 2017

publication date

1 January 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

8 Suppl 2

1 reference

4 August 2017

page(s)

110-114

1 reference

Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Functions of oral candidiasis episodes that are highly prognostic for AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Predictors of mortality among HIV-infected women in Kigali, Rwanda

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Bacillary angiomatosis affecting the oral cavity. Report of two cases and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Intraoral non-Hodgkin's lymphoma in seven patients with acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Human immunodeficiency virus disease: changing patterns of intraocular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Oral hairy leukoplakia and oral candidiasis as predictors of HIV viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Predicting outcomes in HIV-infected veterans: II. Survival after AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Relationship of circulating CD4+ T-lymphocytes and p24 antigenemia to the risk of developing AIDS in HIV-infected subjects with oral hairy leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

HIV viral load markers in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Bacillary angiomatosis by Bartonella quintana in an HIV-infected patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Oral lesions among women living with or at risk for HIV infection. HIV Epidemiology Research Study (HERS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Effect of receptive oral sex and smoking on the incidence of hairy leukoplakia in HIV-positive gay men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

Reduction of HIV-associated oral lesions after highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

A prospective study of oral lesions and their predictive value for progression of HIV disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

Oral lesions as markers of severe immunosuppression in HIV-infected homosexual men and injection drug users

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonovir

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: a 2-year study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

Oral manifestations of pediatric vertical HIV infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

Association of cutaneous and oral diseases in HIV-infected men

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

Clinical signs and laboratory markers in predicting progression to AIDS in HIV–1 infected patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

Oral lesions in children with perinatally acquired human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

Oral lesions in Thai heterosexual AIDS patients: a preliminary study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

Oral manifestations of HIV in a southeast USA population.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

Oral candidosis in HIV-infected patients. Prognostic value and correlation with immunological parameters

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

HIV topic update: protease inhibitor therapy and oral health care

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

Prognostic value of oral candidosis and hairy leukoplakia in 111 Mexican HIV-infected patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

Effect of HAART on natural history of AIDS-related opportunistic disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00021.X

7 January 2021

10.1034/J.1601-0825.2002.00021.X

Identifiers

DOI

1 reference

4 August 2017

1 reference